OPAL LABORATORIES products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Karachi · Pakistan
Long-established Karachi pharmaceutical manufacturer with general, cephalosporin and nutraceutical facilities and domestic/export operations.
OPAL LABORATORIES products in Pakistan
OPAL LABORATORIES (PVT) LTD has 59 medicine presentations registered in Pakistan under 27 brands, covering 25 generic medicines. Most of its products are in Anti-infectives, Vitamins, minerals & nutrition and Respiratory & allergy. Its brands with the most registered strengths and packs are MURBEX (Cephalexin), VENCEF (Cefixime), Z-MAC (Azithromycin) and FERFIX (Elemental iron + Folic acid). 59 products have an official DRAP price on MedInfoBase. See all 27 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Opal Laboratories (Private) Limited
- Company type
- Private pharmaceutical manufacturer
- Address
- LC-41 LITE, Landhi, Karachi, Pakistan
- Website
- opal-labs.com ↗
- Phone
- +92 21 35011047; +92 21 35011046
- info@opal-labs.com
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 88%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where OPAL LABORATORIES (PVT) LTD is priced against the market
51 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| ATADINE TABLTS | Loratadine | 10 mg | Tablet | 10’S | 027675 | PKR 268.49 | PKR 26.85/tablet | 🔒 Pharma Pro |
| DURAMOX | Moxifloxacin | 400 MG | Tablet | 5’S | 035823 | PKR 994.57 | PKR 198.91/tablet | 🔒 Pharma Pro |
| Excipro | Ciprofloxacin | 250 mg | Tablet | 1 X 10’S | 017228 | PKR 367.99 | PKR 36.80/tablet | 🔒 Pharma Pro |
| Excipro | Ciprofloxacin | 500 mg | Tablet | 1 X 10’S | 017229 | PKR 647.68 | PKR 64.77/tablet | 🔒 Pharma Pro |
| FERFIX | Elemental iron + Folic acid | 50 mg + 0.35 mg | Syrup | 120ml | 048548 | PKR 287.58 | PKR 2.40/mL | 🔒 Pharma Pro |
| FERFIX | Elemental iron + Folic acid | 50 mg + 0.35 mg | Syrup | 60ml | 048548 | PKR 151.36 | PKR 2.52/mL | 🔒 Pharma Pro |
| FERFIX | Elemental iron + Folic acid | 50 mg + 0.35 mg | Oral drops | 15ML | 048549 | PKR 140.54 | PKR 9.37/mL | No comparator |
| FERFIX FA CHEWABLE | Elemental Iron | 100 mg | Chewable tablet | 20'S | 048547 | PKR 274.69 | PKR 13.73/tablet | 🔒 Pharma Pro |
| FERFIX FA CHEWABLE IRON III HPM COMPLEX | Folic acid | 100 mg | Chewable tablet | 10'S | 048547 | PKR 144.57 | PKR 14.46/tablet | 🔒 Pharma Pro |
| FLORID | Clomifene citrate | 50 mg | Tablet | 30'S | 075806 | PKR 1,188.84 | PKR 39.63/tablet | 🔒 Pharma Pro |
| FLORID | Clomifene citrate | 50 MG | Tablet | 10'S | 075806 | PKR 446.11 | PKR 44.61/tablet | 🔒 Pharma Pro |
| LEVO-F | Levofloxacin | 250 mg | Tablet | 10'S | 042371 | PKR 516.33 | PKR 51.63/tablet | 🔒 Pharma Pro |
| LEVO-F | Levofloxacin | 500 mg | Tablet | 10'S | 042372 | PKR 859.17 | PKR 85.92/tablet | 🔒 Pharma Pro |
| LISINOCARE | Lisinopril | 10 mg | Tablet | 10’S | 037955 | PKR 202.20 | PKR 20.22/tablet | 🔒 Pharma Pro |
| LISINOCARE | Lisinopril | 5.4450 mg | Tablet | 10’S | 039349 | PKR 113.43 | PKR 11.34/tablet | No comparator |
| MACNAZ | Miconazole | 20 mg/g | Cream | 25GM | 075803 | PKR 217.58 | PKR 8.70/g | 🔒 Pharma Pro |
| MACNAZ | Miconazole | 20 mg/g | Cream | 20GM | 075803 | PKR 177.98 | PKR 8.90/g | 🔒 Pharma Pro |
| MALTHER | Artemether + Lumefantrine | 20 mg + 120 mg | Tablet | 2 X 8’S | 039347 | PKR 660.90 | PKR 41.31/tablet | 🔒 Pharma Pro |
| MALTHER | Artemether + Lumefantrine | 40 mg + 240 mg | Tablet | 8'S | 053372 | PKR 545.24 | PKR 68.16/tablet | 🔒 Pharma Pro |
| MALTHER | Artemether + Lumefantrine | 80 MG + 480 MG | Tablet | 6'S | 066801 | PKR 681.55 | PKR 113.59/tablet | 🔒 Pharma Pro |
| MURBEX | Cephalexin | 250 mg | Tablet | 16'S | 031145 | PKR 188.46 | PKR 11.78/tablet | No comparator |
| MURBEX | Cephalexin | 250 mg | Tablet | 12'S | 031145 | PKR 152.83 | PKR 12.74/tablet | No comparator |
| MURBEX | Cephalexin | 500 mg | Tablet | 16'S | 031146 | PKR 340.78 | PKR 21.30/tablet | No comparator |
| MURBEX | Cephalexin | 500 mg | Tablet | 12'S | 031146 | PKR 309.80 | PKR 25.82/tablet | No comparator |
| MURBEX | Cephalexin | 125 mg/5 mL | Suspension | 60ML | 031147 | PKR 105.33 | PKR 1.76/mL | 🔒 Pharma Pro |
| MURBEX | Cephalexin | 250 MG/5 mL | Suspension | 60ML | 031148 | PKR 183.81 | PKR 3.06/mL | 🔒 Pharma Pro |
| O-Dex Ophthalmic SolutionRegistry verified | Tobramycin/Dexamethasone | — | — | — | 000459-EXOfficial source ↗ | No indexed price | — | — |
| OEZI | Zinc sulfate monohydrate | 10 mg | Tablet | 20'S | 067261 | PKR 123.92 | PKR 6.20/tablet | 🔒 Pharma Pro |
| OEZI | Zinc sulfate | 20 mg | Tablet | 30'S | 067262 | PKR 309.80 | PKR 10.33/tablet | 🔒 Pharma Pro |
| Opa | Hydroxychloroquine | 200 mg | Tablet | 5 x 10'S | 105375 | PKR 675.31 | PKR 13.51/tablet | 🔒 Pharma Pro |
| Opa | Hydroxychloroquine | 200 mg | Tablet | 3 x 10'S | 105375 | PKR 405.18 | PKR 13.51/tablet | 🔒 Pharma Pro |
| OPALAC | Lactulose | 67 g | Syrup | 120ML | 029311 | PKR 305.67 | PKR 2.55/mL | No comparator |
| OPOZOL | Metronidazole | 200 MG | Tablet | 10 X 10’S | 004972 | PKR 250.24 | PKR 2.50/tablet | 🔒 Pharma Pro |
| OPOZOL | Metronidazole | 400 MG | Tablet | 10 X 10’S | 011601 | PKR 363.21 | PKR 3.63/tablet | 🔒 Pharma Pro |
| OPOZOL | Metronidazole | 200 MG/5 mL | Suspension | 60ML | 012039 | PKR 69.49 | PKR 1.16/mL | 🔒 Pharma Pro |
| PRAMEASE | Escitalopram | 10 mg | Tablet | 14'S | 036323 | PKR 818.67 | PKR 58.48/tablet | 🔒 Pharma Pro |
| PRAMEASE | Escitalopram | 10 MG | Tablet | 10'S | 036323 | PKR 616.47 | PKR 61.65/tablet | 🔒 Pharma Pro |
| REDULEX | Omeprazole | 20 mg | Capsule | 2 X 7'S | 027676 | PKR 318.06 | PKR 22.72/capsule | 🔒 Pharma Pro |
| REDULEX | Omeprazole | 20 mg | Capsule | 10’S | 027676 | PKR 227.18 | PKR 22.72/capsule | 🔒 Pharma Pro |
| Relix 20mg CapsuleRegistry verified | Esomeprazole magnesium eq. to Esomeprazole | — | — | — | 035675Official source ↗ | No indexed price | — | — |
| SASTOR | Amlodipine | 5 mg | Tablet | 20'S | 076761 | PKR 681.55 | PKR 34.08/tablet | 🔒 Pharma Pro |
| SASTOR | Amlodipine | 10 mg | Tablet | 20'S | 076762 | PKR 784.82 | PKR 39.24/tablet | 🔒 Pharma Pro |
| Silvigra Tablet 100mgRegistry verified | Sildenafil Citrate Eq. to Sildenafil | — | — | — | 135049Official source ↗ | No indexed price | — | — |
| Silvigra Tablet 50mgRegistry verified | Sildenafil Citrate | — | — | — | 135048Official source ↗ | No indexed price | — | — |
| SINEASE | Loratadine | 5 mg/5 mL | Syrup | 60ML | 030394 | PKR 116.11 | PKR 1.94/mL | 🔒 Pharma Pro |
| SINEASE | Loratadine | 5 mg/5 mL | Syrup | 30ML | 030394 | PKR 53.70 | PKR 1.79/mL | 🔒 Pharma Pro |
| SINEASE DISP | Loratadine | 10 mg | Tablet | 10’S | 030396 | PKR 154.90 | PKR 15.49/tablet | 🔒 Pharma Pro |
| TORRSAM | Ferrous sulfate + Folic acid | 150 mg + 0.5 mg | Tablet | 3 X 10’S | 029308 | PKR 67.57 | PKR 2.25/tablet | 🔒 Pharma Pro |
| VENCEF | Cefixime | 400 mg | Capsule | 5’S | 032024 | PKR 592.04 | PKR 118.41/capsule | 🔒 Pharma Pro |
| VENCEF | Cefixime | 200 mg/5 mL | Suspension | 60ML | 032025 | PKR 671.22 | PKR 11.19/mL | 🔒 Pharma Pro |
All 27 OPAL LABORATORIES brands in Pakistan
- ATADINE TABLTS Loratadine · 10 mg tablet
- DURAMOX Moxifloxacin · 400 MG tablet
- Excipro Ciprofloxacin · 250 mg tablet, 500 mg tablet
- FERFIX Elemental iron + Folic acid · 50 mg + 0.35 mg syrup, 50 mg + 0.35 mg drops
- FERFIX FA CHEWABLE Elemental Iron · 100 mg tablet
- FERFIX FA CHEWABLE IRON III HPM COMPLEX Folic acid · 100 mg tablet
- FLORID Clomifene citrate · 50 MG tablet
- LEVO-F Levofloxacin · 250 mg tablet, 500 mg tablet
- LISINOCARE Lisinopril · 10 mg tablet, 5.4450 mg tablet
- MACNAZ Miconazole · 20 mg/g cream
- MALTHER Artemether + Lumefantrine · 20 mg + 120 mg tablet, 40 mg + 240 mg tablet, 80 MG + 480 MG tablet
- MURBEX Cephalexin · 125 mg/5 mL suspension, 250 mg tablet, 250 MG/5 mL suspension
- OEZI Zinc sulfate monohydrate, Zinc sulfate · 10 mg tablet, 20 mg tablet
- Opa Hydroxychloroquine · 200 mg tablet
- OPALAC Lactulose · 67 g syrup
- OPOZOL Metronidazole · 200 MG tablet, 200 MG/5 mL suspension, 400 MG tablet
- PRAMEASE Escitalopram · 10 MG tablet
- REDULEX Omeprazole · 20 mg capsule
- SASTOR Amlodipine · 10 mg tablet, 5 mg tablet
- SINEASE Loratadine · 5 mg/5 mL syrup
- SINEASE DISP Loratadine · 10 mg tablet
- TORRSAM Ferrous sulfate + Folic acid · 150 mg + 0.5 mg tablet
- VENCEF Cefixime · 100 mg/5 mL suspension, 200 MG tablet, 200 mg/5 mL suspension
- VENRITH Clarithromycin · 125 MG/5 mL syrup, 250 mg tablet, 500 mg tablet
- WATBAL FRUIT Sodium chloride · 2.6 g sachet
- WATBAL ORANGE Sodium chloride · 2.6 g sachet
- Z-MAC Azithromycin · 100 mg/5 mL suspension, 200 mg/5 mL suspension, 250 mg capsule
OPAL LABORATORIES: common questions
How many products does OPAL LABORATORIES have in Pakistan?
OPAL LABORATORIES (PVT) LTD has 59 registered medicine presentations in Pakistan, sold under 27 brands and covering 25 generic medicines.
What are the main brands of OPAL LABORATORIES?
By number of registered strengths and packs, its largest brands are MURBEX (Cephalexin), VENCEF (Cefixime), Z-MAC (Azithromycin), FERFIX (Elemental iron + Folic acid) and MALTHER (Artemether + Lumefantrine). This is not a sales ranking.
Which therapy areas does OPAL LABORATORIES cover?
The most products are in Anti-infectives (34), Vitamins, minerals & nutrition (8), Respiratory & allergy (4), Cardiovascular (4) and Gastrointestinal & hepatology (3).
Where can I see OPAL LABORATORIES medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.
